These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24040445)

  • 1. Assessing the role of IL-35 in colorectal cancer progression and prognosis.
    Zeng JC; Zhang Z; Li TY; Liang YF; Wang HM; Bao JJ; Zhang JA; Wang WD; Xiang WY; Kong B; Wang ZY; Wu BH; Chen XD; He L; Zhang S; Wang CY; Xu JF
    Int J Clin Exp Pathol; 2013; 6(9):1806-16. PubMed ID: 24040445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changes of Th17 cells and the related cytokines in the progression of human colorectal cancers.
    Wang J; Xu K; Wu J; Luo C; Li Y; Wu X; Gao H; Feng G; Yuan BZ
    BMC Cancer; 2012 Sep; 12():418. PubMed ID: 22994684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3.
    Ma Y; Chen L; Xie G; Zhou Y; Yue C; Yuan X; Zheng Y; Wang W; Deng L; Shen L
    Oncotarget; 2016 Nov; 7(45):73003-73015. PubMed ID: 27682874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th22 cell accumulation is associated with colorectal cancer development.
    Huang YH; Cao YF; Jiang ZY; Zhang S; Gao F
    World J Gastroenterol; 2015 Apr; 21(14):4216-24. PubMed ID: 25892871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
    Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
    J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
    Cui G; Yuan A; Li Z; Goll R; Florholmen J
    Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway.
    Liang Y; Chen Q; Du W; Chen C; Li F; Yang J; Peng J; Kang D; Lin B; Chai X; Zhou K; Zeng J
    Mediators Inflamm; 2016; 2016():3214105. PubMed ID: 27247488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
    Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
    Front Immunol; 2020; 11():550250. PubMed ID: 33193316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant and Conflicting Correlation of IL-9 With
    Niccolai E; Russo E; Baldi S; Ricci F; Nannini G; Pedone M; Stingo FC; Taddei A; Ringressi MN; Bechi P; Mengoni A; Fani R; Bacci G; Fagorzi C; Chiellini C; Prisco D; Ramazzotti M; Amedei A
    Front Immunol; 2020; 11():573158. PubMed ID: 33488574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
    Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
    Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive nomogram of the clinical outcomes of colorectal cancer based on methylated SEPT9 and intratumoral IL-10
    Sun J; Shi S; Sun C; Wang J; Yang X; Yang Z; Xu J; Zhang S
    J Transl Med; 2024 Sep; 22(1):861. PubMed ID: 39334238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis.
    Yang Y; Wang Z; Zhou Y; Wang X; Xiang J; Chen Z
    World J Surg Oncol; 2015 Apr; 13():146. PubMed ID: 25889282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
    Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.
    Cui G; Qi H; Gundersen MD; Yang H; Christiansen I; Sørbye SW; Goll R; Florholmen J
    Cancer Immunol Immunother; 2015 Feb; 64(2):181-90. PubMed ID: 25324197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer.
    Saleh R; Taha RZ; Toor SM; Sasidharan Nair V; Murshed K; Khawar M; Al-Dhaheri M; Petkar MA; Abu Nada M; Elkord E
    Cancer Immunol Immunother; 2020 Oct; 69(10):1989-1999. PubMed ID: 32393998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.